Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 8YAZ/Yasim/Yasminelle

02 1YAZTM/YasimTM/YasminelleTM

03 2Yaz/Yasim/Yasminelle

PharmaCompass

01

Brand Name : YAZ/Yasim/Yasminelle

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothBayer AG manufactures innovative APIs and pharmaceutical formulations across diverse therapeutic areas.

Drospirenone, Ethinylestradiol

Main Therapeutic Indication : Urology

Currency : USD

2020 Revenue in Millions : 810

2019 Revenue in Millions : 824

Growth (%) : -2

Company Banner

02

Brand Name : YAZ/Yasim/Yasminelle

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothBayer AG manufactures innovative APIs and pharmaceutical formulations across diverse therapeutic areas.

Drospirenone, Ethinylestradiol

Main Therapeutic Indication : Urology

Currency : USD

2021 Revenue in Millions : 815

2020 Revenue in Millions : 810

Growth (%) : 10

Company Banner

03

Brand Name : YAZ/Yasim/Yasminelle

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothBayer AG manufactures innovative APIs and pharmaceutical formulations across diverse therapeutic areas.

Drospirenone, Ethinylestradiol

Main Therapeutic Indication : Women's Health

Currency : USD

2022 Revenue in Millions : 830

2021 Revenue in Millions : 815

Growth (%) : 2

Company Banner

04

Brand Name : YAZ/Yasim/Yasminelle

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothBayer AG manufactures innovative APIs and pharmaceutical formulations across diverse therapeutic areas.

Drospirenone, Ethinylestradiol

Main Therapeutic Indication : Women's Health

Currency : USD

2023 Revenue in Millions : 727

2022 Revenue in Millions : 830

Growth (%) : -15

Company Banner

05

Brand Name : YAZ/Yasim/Yasminelle

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothBayer AG manufactures innovative APIs and pharmaceutical formulations across diverse therapeutic areas.

Drospirenone, Ethinylestradiol

Main Therapeutic Indication : Women?s Health

Currency : USD

2024 Revenue in Millions : 693

2023 Revenue in Millions : 727

Growth (%) : -5

Company Banner

06

Brand Name : YAZ/Yasim/Yasminelle

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothBayer AG manufactures innovative APIs and pharmaceutical formulations across diverse therapeutic areas.

Drospirenone, Ethinyl Estradiol

Main Therapeutic Indication : Sexual Health

Currency : USD

2015 Revenue in Millions : 845

2014 Revenue in Millions : 777

Growth (%) : -8%

Company Banner

07

Brand Name : YAZTM/YasimTM/YasminelleTM

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothBayer AG manufactures innovative APIs and pharmaceutical formulations across diverse therapeutic areas.

Drospirenone, Ethinyl Estradiol

Main Therapeutic Indication : Sexual Health

Currency : USD

2014 Revenue in Millions : -10.00%

2013 Revenue in Millions :

Growth (%) :

Company Banner

08

Brand Name : YAZ/Yasim/Yasminelle

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothBayer AG manufactures innovative APIs and pharmaceutical formulations across diverse therapeutic areas.

Drospirenone, Ethinyl Estradiol

Main Therapeutic Indication : Sexual Health

Currency : USD

2017 Revenue in Millions : 804

2016 Revenue in Millions : 841

Growth (%) : -4

Company Banner

09

Brand Name : Yaz/Yasim/Yasminelle

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothBayer AG manufactures innovative APIs and pharmaceutical formulations across diverse therapeutic areas.

Drospirenone, Ethinyl Estradiol

Main Therapeutic Indication : Sexual Health

Currency : USD

2016 Revenue in Millions : 719

2015 Revenue in Millions : 748

Growth (%) : -4

Company Banner

10

Brand Name : Yaz/Yasim/Yasminelle

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothBayer AG manufactures innovative APIs and pharmaceutical formulations across diverse therapeutic areas.

Drospirenone, Ethinyl Estradiol

Main Therapeutic Indication : Sexual Health

Currency : USD

2018 Revenue in Millions : 722

2017 Revenue in Millions : 732

Growth (%) : -1%

Company Banner